ID :
157737
Tue, 01/18/2011 - 11:38
Auther :
Shortlink :
https://oananews.org//node/157737
The shortlink copeid
SINGAPORE UNIVERSITY INVENTS NOVEL ECG CHIP
SINGAPORE, Jan 18 (Bernama) -– The National University of Singapore (NUS)has
invented an ultra-low powered and fully-integrated electrocardiogram (ECG) chip
that also continuously records for seven days.
Current cardiac ECG recording devices tend to have short operating lives, and
often have difficulty in capturing the sporadic abnormal heart episodes.
Singapore’s Agency for Science, Technology and Research (A*STAR) that funded the
research on the invention, said today NUS planned to commercialise the chip for
the global market and that it had set up a company called ‘Clearbridge
VitalSigns’ for the purpose.
The current cardiac monitoring devices were often cumbersome and bulky, which
greatly affected patient comfort and mobility, said A*STAR in a statement
Monday.
In contrast, the ECG chip could be developed into an extremely thin,
self-adhesive ‘Digital ECG Plaster’ that could be adhered to a patient’s chest,
the agency said.
The primary use of the ECG device is to monitor patients with heart problems or
those who have undergone heart surgery, and it can also be used by professional
athletes who undergo strenuous physical training.
-- BERNAMA
invented an ultra-low powered and fully-integrated electrocardiogram (ECG) chip
that also continuously records for seven days.
Current cardiac ECG recording devices tend to have short operating lives, and
often have difficulty in capturing the sporadic abnormal heart episodes.
Singapore’s Agency for Science, Technology and Research (A*STAR) that funded the
research on the invention, said today NUS planned to commercialise the chip for
the global market and that it had set up a company called ‘Clearbridge
VitalSigns’ for the purpose.
The current cardiac monitoring devices were often cumbersome and bulky, which
greatly affected patient comfort and mobility, said A*STAR in a statement
Monday.
In contrast, the ECG chip could be developed into an extremely thin,
self-adhesive ‘Digital ECG Plaster’ that could be adhered to a patient’s chest,
the agency said.
The primary use of the ECG device is to monitor patients with heart problems or
those who have undergone heart surgery, and it can also be used by professional
athletes who undergo strenuous physical training.
-- BERNAMA